Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)
CNY 2.75
(-0.36%)
CNY 2.75
(-0.36%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.47 Billion CNY | -6.43% |
| 2022 | 5.85 Billion CNY | 7.8% |
| 2021 | 5.43 Billion CNY | -17.03% |
| 2020 | 6.54 Billion CNY | 6.56% |
| 2019 | 6.14 Billion CNY | 1.57% |
| 2018 | 6.04 Billion CNY | 5.74% |
| 2017 | 5.72 Billion CNY | 5.28% |
| 2016 | 5.43 Billion CNY | 13.16% |
| 2015 | 4.8 Billion CNY | 116.22% |
| 2014 | 2.22 Billion CNY | 53.46% |
| 2013 | 1.44 Billion CNY | 16.92% |
| 2012 | 1.23 Billion CNY | 9.7% |
| 2011 | 1.12 Billion CNY | 281.43% |
| 2010 | 295.77 Million CNY | 59.25% |
| 2009 | 185.73 Million CNY | 51.77% |
| 2008 | 122.37 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 5.46 Billion CNY | -0.31% |
| 2024 Q3 | 5.39 Billion CNY | -0.62% |
| 2024 Q2 | 5.42 Billion CNY | -0.62% |
| 2023 Q2 | 5.58 Billion CNY | -0.28% |
| 2023 Q3 | 5.52 Billion CNY | -1.08% |
| 2023 FY | 5.47 Billion CNY | -6.43% |
| 2023 Q1 | 5.6 Billion CNY | -4.36% |
| 2023 Q4 | 5.47 Billion CNY | -0.82% |
| 2022 Q2 | 5.55 Billion CNY | 1.7% |
| 2022 FY | 5.85 Billion CNY | 7.8% |
| 2022 Q4 | 5.85 Billion CNY | 2.75% |
| 2022 Q3 | 5.69 Billion CNY | 2.58% |
| 2022 Q1 | 5.46 Billion CNY | 0.55% |
| 2021 Q1 | 6.82 Billion CNY | 4.23% |
| 2021 Q3 | 6.39 Billion CNY | -1.57% |
| 2021 Q4 | 5.43 Billion CNY | -15.11% |
| 2021 Q2 | 6.5 Billion CNY | -4.74% |
| 2021 FY | 5.43 Billion CNY | -17.03% |
| 2020 Q4 | 6.54 Billion CNY | -1.75% |
| 2020 Q1 | 6.55 Billion CNY | 6.69% |
| 2020 FY | 6.54 Billion CNY | 6.56% |
| 2020 Q3 | 6.66 Billion CNY | -3.1% |
| 2020 Q2 | 6.87 Billion CNY | 4.91% |
| 2019 Q1 | 6.19 Billion CNY | 2.46% |
| 2019 FY | 6.14 Billion CNY | 1.57% |
| 2019 Q4 | 6.14 Billion CNY | -0.68% |
| 2019 Q3 | 6.18 Billion CNY | -0.99% |
| 2019 Q2 | 6.24 Billion CNY | 0.8% |
| 2018 Q1 | 5.78 Billion CNY | 1.1% |
| 2018 Q2 | 5.9 Billion CNY | 2.14% |
| 2018 Q4 | 6.04 Billion CNY | 0.14% |
| 2018 Q3 | 6.04 Billion CNY | 2.26% |
| 2018 FY | 6.04 Billion CNY | 5.74% |
| 2017 Q3 | 6.23 Billion CNY | -2.99% |
| 2017 FY | 5.72 Billion CNY | 5.28% |
| 2017 Q4 | 5.72 Billion CNY | -8.24% |
| 2017 Q2 | 6.42 Billion CNY | 3.13% |
| 2017 Q1 | 6.23 Billion CNY | 14.68% |
| 2016 FY | 5.43 Billion CNY | 13.16% |
| 2016 Q4 | 5.43 Billion CNY | 4.9% |
| 2016 Q3 | 5.17 Billion CNY | 3.57% |
| 2016 Q2 | 5 Billion CNY | 2.18% |
| 2016 Q1 | 4.89 Billion CNY | 1.94% |
| 2015 Q3 | 3.13 Billion CNY | 6.43% |
| 2015 Q2 | 2.94 Billion CNY | 23.27% |
| 2015 Q1 | 2.39 Billion CNY | 7.65% |
| 2015 Q4 | 4.8 Billion CNY | 53.1% |
| 2015 FY | 4.8 Billion CNY | 116.22% |
| 2014 FY | 2.22 Billion CNY | 53.46% |
| 2014 Q2 | 1.76 Billion CNY | 12.35% |
| 2014 Q4 | 2.22 Billion CNY | 21.57% |
| 2014 Q3 | 1.82 Billion CNY | 3.4% |
| 2014 Q1 | 1.57 Billion CNY | 8.66% |
| 2013 Q4 | 1.44 Billion CNY | 7.16% |
| 2013 FY | 1.44 Billion CNY | 16.92% |
| 2013 Q2 | 1.33 Billion CNY | 3.91% |
| 2013 Q3 | 1.35 Billion CNY | 1.38% |
| 2013 Q1 | 1.28 Billion CNY | 3.57% |
| 2012 Q3 | 1.2 Billion CNY | -0.52% |
| 2012 Q1 | 1.23 Billion CNY | 9.54% |
| 2012 Q2 | 1.21 Billion CNY | -1.69% |
| 2012 FY | 1.23 Billion CNY | 9.7% |
| 2012 Q4 | 1.23 Billion CNY | 2.4% |
| 2011 Q3 | 1.13 Billion CNY | 204.88% |
| 2011 Q4 | 1.12 Billion CNY | -0.48% |
| 2011 Q2 | 371.83 Million CNY | 0.0% |
| 2011 FY | 1.12 Billion CNY | 281.43% |
| 2010 FY | 295.77 Million CNY | 59.25% |
| 2010 Q4 | 295.77 Million CNY | 0.0% |
| 2009 FY | 185.73 Million CNY | 51.77% |
| 2008 FY | 122.37 Million CNY | 0.0% |